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The obliteration of the arterial vascular system of toes is considered as a potentially catastrophic event in clinical practices. In
most instances, the cessation of arterial blood ﬂow heralds a serious underlying pathology. A deﬁnite classiﬁcation of some cases
is somehow diﬃcult and subject to diagnostic challenges. The aim of the present case study is to share and discuss potentially
complex and multifactorial mechanisms of some acute vascular events. In this report, we deal with a 46-year-old man with a
rather gradual-onset ischemia of his toe who responded favorably to a combination of pulsed glucocorticoid and anticoagulation
within a week.
1.Introduction
“Blue toe” is due to the occlusion of blood ﬂow in the di-
gital arteries of feet. The obliteration of vascular system is a
potentially catastrophic event in clinical practices. In most
instances, the cessation of arterial blood ﬂow heralds a seri-
ous underlying pathology. Several mechanisms are involved,
butthemostcommoncausesareacutearterio-arterialembo-
lism,in-sitethrombosis,vasospasm,vasculitis,inﬂammatory
thrombosis, and atherosclerosis [1, 2]. The typical featuresof
thementionedscenariosarediagnosedeasilybysomegolden
standards or classiﬁcation criteria. Deﬁnite classiﬁcations
of some cases are somehow diﬃcult and subject to more
discussion. The aim of the present case study is to share and
discuss potentially complex and multifactorial mechanisms
of some acute vascular events. Herein, we describe a 46-year-
old man with a gradual-onset ischemia of his toes who
responded favorably to anti-inﬂammatory agents and anti-
coagulation within a week.
2.CaseReport
A 46-year-old male government employee referredto us with
complains of painful bluish discoloration of his toes that
he had suﬀered for two months. In his past history, he was
chemically injured in Iran-Iraq war in the 1980s without
any signiﬁcant sequella till his reference to us. He was a
smoker, 5 packs per year for 5 years, but he had decreased
it to occasional smoking in recent years. He had no history
of medication or drug use. His problem had started three
months earlier with symptoms suggestive of right lower limb
deep vein thrombosis documented with ultrasound imaging.
His symptoms, complicated with pulmonary manifestations
in which ventilation scan showed a high probability for
pulmonary thromboembolism (PTE), resulted in his hos-
pitalization a month before his last admission. He was on
oral cyclophosphamide 100mg/day and oral prednisolone
20mg/day with a diagnosis of undiﬀerentiated necrotizing
vasculitis in the former center where he referred to us. In his2 Case Reports in Medicine
Figure 1: Ischemic discoloration of left small toe two days after
treatment.
Figure 2: Superﬁcial phlebitis of right shin.
present illness, he complained of excessive sensitivity to the
cold exposure of his extremities and showed features highly
suggestive of Raynaund’s phenomenon. He had no history of
diabetes, hypertension, dyslipidemia, or any other comorbid
condition.
In the physical examination, he showed normal vital
signs and also otherwise normal cardiopulmonary exam.
In the examination of his extremities, he showed ischemic
changes as cold feet with absent dorsalis pedis and posterior
tibialis pulses bilaterally along with the ischemic bluish
discoloration of small toe at left foot (Figure 1). He also
showedtypicalsuperﬁcialthrombophlebitisonanteromedial
aspect of his right arm and shin (Figure 2). Splinter hemo-
rrhages were evident on some of his ﬁnger nails.
In the laboratory investigation, he had a normal blood
cell count with normal diﬀerentiation. His C3, C4, HBs
Antigen, HCV and HIV antibodies, antineutrophil cytoplas-
mic antibodies (anti MPO and PR3), antinuclear antibodies
(Elisa), rheumatoid factor, anti-CCP, anticardiolipin anti-
bodies (Elisa), protein C and S, antithrombin III, factor IV
Leiden, prothrombin and thrombin time, partial thrombo-
plastin time, homocysteine, cryoglobulins, cryoﬁbrinogen,
and renal and liver function tests were all normal. His CH50
showed some degrees of decreased activity (68%), and the
erythrocyte sedimentation rate (Westergren method) was
around 24/min on average.
Figure 3: MR angiogram showing bilateral anterior and posterior
tibial artery occlusion with some collateral vessels.
His D-dimer assay showed an increase three times above
normal. His transthoracic and transesophageal echocardiog-
raphy had normal results. Three consecutive blood cultures
were negative for growing bacteria. Magnetic resonance
angiography (MRA) was consistent with bilateral anterior
and posterior tibialis artery occlusion (Figure 3).
We had no deﬁnite diagnosis at the time of establish-
ing treatment, but we knew that we had to take any use-
ful and safe action to minimize ischemic insult and pre-
vent progression of ischemia. With an assumption of the
possible role of a vascular inﬂammatory disease in setting a
hypercoagulable state or an unusual presentation of throm-
boangiitis obliterans or a combination pathology, we start-
ed to administer pulsed intravenous methylprednisolone
1000mginthreedays,pulsedintravenouscyclophosphamide
500mg at once, pentoxyfylline 400mg three times a day,
aspirin 100mg/day, heparin 1000mg/hour for seven days
overlapping with oral warfarin 5mg/day, amlodipine 5mg
daily, and oral daily dose of prednisolone 50mg/day with
rapid tapering to 2.5mg/day within three weeks after the
institution of the mentioned regimen. A rapid clinical im-
provement with rewarming and reperfusion ensued 5–7 days
later and Splinter hemorrhages vanished about a month
after treatment. After six months of therapy, while he was
on 5mg/day warfarin, 5mg/every other day prednisolone,
aspirin 81mg/day and oral cyclophosphamide 100mg/week
and mesna 50mg/week, there was no complaint of pain and
no clinical cyanosis, but his arterial pulses were still nonpal-
pable. His general condition and function are good now.
3. Discussion
Classic“bluetoesyndrome”usuallyreferstoacyanoticsingle
toe most probably due to atheroembolic phenomena with
a patent proximal artery. However, the clinical spectrum,
diﬀerential diagnosis, and etiologies are wide. Vasospasm,
vasculitis, hyperviscosity syndrome (cold agglutinin ane-
mia), hypercoagulable state, embolism, calciphylaxis, andCase Reports in Medicine 3
toxins (ergot derivatives) are among the most common dif-
ferential diagnoses. Glucocorticoids and some neoplasms [3]
are among the diﬀerential diagnoses of blue toe syndrome.
In typical clinical scenarios (like vascular surgical manip-
ulation of aorta, or index vasoactive drug, typical clinical
along with supporting serologic markers), a single mecha-
nism could be assumed. But in several clinical conditions,
an interaction of multiple factors may play a role in criti-
cal ischemia in toes. In the above-mentioned case, ischemic
discoloration of toes after a thrombotic event aroused the
suspicion of hypercoagulable state that involves arteries.
But a bilateral extensive medium-sized arterial occlusion on
MRA made in-situ thrombosis and vasculitis unlikely as a
sole mechanism. In such settings, warfarin-induced digital
ischemia is an important diagnosis [4], but warfarin had
stopped probably inadvertently after the disposition form
initial hospitalization. So, drug-induced ischemia is less like-
ly too. The MR angiogram denoted a medium-size involve-
ment which was not compatible with the classical and more
common variants of small vessel vasculitic syndromes. The
patient had no convincing evidence (aneurysm or seroposi-
tivityforHBSantigen)tosupportthediagnosisofpolyarteri-
tis nodosa as a vasculitic pathology involving medium-
size vessels. Splinter hemorrhage and superﬁcial thrombo-
phlebitis are the characteristic features of hypercoagulable
(antiphospholipid antibody) syndrome or thromboangiitis
obliterans (TAO), but occasional cigarette smoking and ab-
sence of typical angiographic corkscrew pattern are incon-
sistent with typical TAO. While typical angiographic pattern
is seen in around 17% of TA cases, MRA could miss this
pattern in respect to conventional contrast enhanced classic
angiography due to some technical limitations. TAO can oc-
cur in 5 percent without any history of smoking [5]. Mul-
tiple thromboembolism of the pulmonary artery has been
reported in caseswithTAO. Seronegative antiphospholipid is
a possible diagnosis covering this clinical scenario [6, 7]. No
relationship between chemical war injuries and thrombotic
events was found in our search. Atherosclerotic peripheral
arterial disease (PAD) is usually seen in elderly people with
prominent proximal intimal lesions or a history of diabetes
mellitus or dyslipidemia. So in the present case,the diagnosis
ofatheroscleroticperipheralvasculardiseaseisunacceptable.
The gradual onset of clinical course, bilateral occlusion with
clear bifurcations, and redistribution to collateral arteries
are the strong pieces of evidence against acute thromboem-
bolism. Also, the patient’s chronic presentation with rather
good collaterals negatively addresses a diagnosis of classic
vasculitis in this case. The rapid restoration of clinical
ischemia in this case denotes a more easily reversible compo-
nent of vascular insult which could be a vascular inﬂamma-
tory condition. This could be the sine qua non of vasculitides
or forme frusta of TAO or even an apparently noninﬂamma-
tory condition such as Raynaud’s phenomenon [8].
Treatment of a known background disease could cause a
complete to partial improvement in ischemic toes.
Weconcludethat,intheclinicalsettingofcriticalischem-
ia with an indeﬁnite mechanism, any clinician should con-
sider a cocktail protocol including vasodilators, antiplatelet
agent, anticoagulation, and pulsed glucocorticoid with or
without vasodilatory prostaglandins (PG) such as PGI2 (Io-
prost) or PGE1 (Alprostadil) as a salvage treatment until a
deﬁnite diagnosis is made.
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